American Century Companies Inc Co Diagnostics, Inc. Transaction History

American Century Companies Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.04 - $1.64 $218,198 - $344,081	-209,806 Reduced 94.85%	11,393 $12,000
Q1 2023 May 11, 2023	BUY	$1.39 - $3.24 $11,534 - $26,885	8,298 Added 3.9%	221,199 $327,000
Q4 2022 Feb 13, 2023	BUY	$2.32 - $3.68 $61,554 - $97,637	26,532 Added 14.24%	212,901 $536,000
Q3 2022 Nov 14, 2022	BUY	$2.87 - $7.01 $240,922 - $588,454	83,945 Added 81.96%	186,369 $598,000
Q2 2022 Aug 12, 2022	BUY	$3.76 - $6.29 $87,502 - $146,380	23,272 Added 29.4%	102,424 $575,000
Q1 2022 May 11, 2022	BUY	$5.03 - $9.61 $76,647 - $146,437	15,238 Added 23.84%	79,152 $489,000
Q4 2021 Feb 07, 2022	BUY	$8.12 - $10.37 $518,981 - $662,788	63,914 New	63,914 $571,000

4.51M

3.3K

198K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $41.6M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.